Skip to main content

Table 2 Baseline predictors of treatment success (viral load<400 copies) among HIV-infected infants 6 months after ART initiation

From: Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda

Characteristic Univariate OR P-value Multivariable OR P-value
  (95% CI)   (95% CI)  
Age (>6 months) 0.83 (0.31-2.24) 0.718 1.20 (0.33-4.37) 0.785
Sex (Male) 1.01 (0.37-2.74) 0.990 0.77 (0.24-2.45) 0.657
CD4 percent (every 1%) 0.99 (0.94-1.04) 0.670 0.95 (0.89-1.01) 0.123
WHO stage (stage3&4) 0.43 (0.15-1.23) 0.116 0.33 (0.08-1.14) 0.078
Protease Inhibitor 1.34 (0.45-4.02) 0.603 1.33 (038-4.65) 0.657
Weight for Age Z-score (<-2) 0.63 (0.21-1.85) 0.395 0.40 (0.09-1.76) 0.227
Height for age Z-score (<-2) 1.44 (0.50-4.12) 0.500 2.08 (0.58-7.47) 0.260
  1. ART= antiretroviral therapy; OR= Odds Ratio; CI= Confidence Interval; WHO= World Health Organization.
\